Amgen Inc logo

Amgen Inc

XTER:AMG (USA)   Ordinary Shares
€ 243.20 (+0.5%) Nov 29
18.81
P/B:
18.49
Market Cap:
€ 129.66B ($ 142.22B)
Enterprise V:
€ 153.04B ($ 167.87B)
Volume:
222.00
Avg Vol (2M):
502.00
Also Trade In:
Volume:
222.00
Avg Vol (2M):
502.00

Business Description

Description
Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). The 2023 Horizon acquisition brings several rare disease drugs, including thyroid eye disease drug Tepezza. Amgen also has a growing biosimilar portfolio.

Financials (Next Earnings Date:2024-01-31 Est.)

XTER:AMG's 30-Y Financials
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014

Amgen Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 25,074.275
EPS (TTM) (€) 13.153
Beta 0.17
Volatility % 21.53
14-Day RSI 41.94
14-Day ATR (€) 3.748948
20-Day SMA (€) 246.56
12-1 Month Momentum % -7.57
52-Week Range (€) 196.6 - 276.95
Shares Outstanding (Mil) 535.18

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 7
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Amgen Inc Filings

Filing Date Document Date Form
No Filing Data

Amgen Inc Stock Events

Event Date Price(€)
No Event Data

Amgen Inc Frequently Asked Questions

What is Amgen Inc(XTER:AMG)'s stock price today?
The current price of XTER:AMG is €243.20. The 52 week high of XTER:AMG is €276.95 and 52 week low is €196.60.
When is next earnings date of Amgen Inc(XTER:AMG)?
The next earnings date of Amgen Inc(XTER:AMG) is 2024-01-31 Est..
Does Amgen Inc(XTER:AMG) pay dividends? If so, how much?
The  Dividend Yield %  of Amgen Inc(XTER:AMG) is 3.29% (As of Today), Highest Dividend Payout Ratio of Amgen Inc(XTER:AMG) was 1.71. The lowest was 0.28. And the median was 0.43. The  Forward Dividend Yield % of Amgen Inc(XTER:AMG) is 3.23%. For more information regarding to dividend, please check our Dividend Page.

Press Release

Subject Date
No Press Release